
AbbVie, Pure MHC sign cancer alliance
Executive Summary
Pure Protein LLC's subsidiary Pure MHC LLC is teaming up with AbbVie Inc. in the discovery and validation of peptide targets for use with T-cell receptor therapies aimed at various cancers.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
- Immuno-Oncology
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com